Mutations in extensively drug-resistant mycobacterium tuberculosis that do not code for known drug-resistance mechanisms

Journal of Infectious Diseases

Volumn 201, Issue 6, 2010, Pages 881-888

  Motiwala, Alifiya S ^a   Dai, Yang ^a   Jones López, Edward C ^a   Hwang, Soo Hee ^b   Lee, Jong Seok ^c   Cho, Sang Nae ^d   Via, Laura E ^e   Barry Iii, Clifton E ^e   Alland, David ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b National Masan Hospital   (South Korea)

^c International Tuberculosis Research Center   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG SENSITIVITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOPHYLY; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; DATABASES, NUCLEIC ACID; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENES, MDR; HIV INFECTIONS; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 77749267930     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650999     Document Type: Article

References (16)

1. LoBue P. Extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2009; 22:167-173.
2. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-1580. (Pubitemid 44780738)
3. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79:3-29.
4. Gagneux S. Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2009; 15(Suppl 1):66-68.
5. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312:1944-1946.
6. Koenig R. Tuberculosis: few mutations divide some drug-resistant TB strains. Science 2007; 318:901-902. (Pubitemid 350098961)
7. Broad Institute TB Web site. http://www.broad.mit.edu/annotation/genome/ mycobacterium-tuberculosis-spp/ToolsIndex.html. Accessed 11 January 2008.
8. Hazbon MH, Motiwala AS, Cavatore M, Brimacombe M, Whittam TS, Alland D. Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2008; 52:3369-3376.
9. Hazbon MH, Bobadilla del Valle M, Guerrero MI, et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-3802.
10. Hazbon MH, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50:2640-2649.
11. Alland D, Lacher DW, Hazbon MH, et al. Role of large sequence polymorphisms (LSPs) in generating genomic diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in phylogenetic analysis. J Clin Microbiol 2007; 45:39-46.
12. Filliol I, Motiwala AS, Cavatore M, et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006; 188:759-772.
13. Cole ST. Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 2002; 148:2919-2928.
14. Raghavan S, Manzanillo P, Chan K, Dovey C, Cox JS. Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature 2008;454:717-721.
15. Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 2002; 70:4955-4960.
16. Safi H, Sayers B, Hazbon MH, Alland D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 2008; 52:2027-2034.